Liminatus Pharma Financial Overview
Liminatus Pharma's market cap is currently $21.38M. The company's EPS TTM is $; its P/E ratio is -4.26; Liminatus Pharma is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.